Intensity Therapeutics Investor Relations Material
Latest events
AGM 2024
Intensity Therapeutics
Q1 2025
12 May, 2025
Q4 2024
12 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Intensity Therapeutics Inc
Access all reports
Intensity Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of cancer immunotherapies. The company's lead platform is designed to deliver therapeutic agents directly into tumors to stimulate immune activation and systemic anti-cancer effects. Its development activities span preclinical research through clinical trials targeting various solid tumors. Intensity Therapeutics Inc is headquartered in Westport, Connecticut, and its shares are listed on the NASDAQ.
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
INTS
Country
🇺🇸 United States